-
Product Insights
D R Burton Healthcare LLC, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: D R Burton Healthcare LLC, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these...
-
Company Profile
St. Modwen Properties Ltd – Company Profile
St. Modwen Properties Ltd (St. Modwen) is a real estate investment company. It carries out the development of properties in partnership with private and public sector organizations. The company’s portfolio comprises a range of properties such as industrial, mixed-use or community, leisure, residential, business parks, town centers, and retail. St. Modwen offers properties under the brand name St. Modwen Homes. It serves e-commerce companies, logistics firms, and other specialist businesses in the UK. Its properties include St. Modwen Park Burton,...
Add to Basket -
Company Profile
Clinigen Ltd – Company Profile
Clinigen Ltd (Clinigen) is a pharmaceutical and services company that provides access to clinical trials, medicines and unlicensed and commercial supplies. The company’s products include dexrazoxane, crisantaspase, amifostine, foscarnet sodium, acetylcysteine, cholecalciferol, folic acid, gabapentin, glycopyrronium bromide, iloprost, and others. It carries out clinical trial services, partnering, IDIS-managed access, clinical supply management, and others. Clinigen's clinical trial services comprise packaging and labeling, direct-to-site delivery, global storage and distribution, ancillary supply sourcing, and controlled drug services. The company serves biotechnology and...
Add to Basket -
Product Insights
Quarterly Cookies (Sweet Biscuits) pricing trends in Hong Kong
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Cookies (Sweet Biscuits) pricing trends in Hong Kong" serves as a crucial resource...
-
Product Insights
One Burton
Equip yourself with the essential tools needed to make informed and profitable decisions with our One Burton report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? ·Unleash the full story: Dive deep into the One Burton project and unravel...
-
Product Insights
Net Present Value Model: Branebrutinib
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Branebrutinib Drug Details Branebrutinib (BMS-986195) is...
-
Product Insights
Net Present Value Model: GB-5121
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model GB-5121 Drug Details GB-5121 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GB-5121
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GB-5121 Drug Details GB-5121 is under development for the treatment of relapsed or refractory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – branebrutinib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry branebrutinib Drug Details Branebrutinib (BMS-986195) is under development for the treatment of moderate to...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CT-1530
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CT-1530 Drug Details CT-1530 is under development for the treatment of relapsed or refractory...